Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;38(4):1498-501.
doi: 10.1128/JCM.38.4.1498-1501.2000.

New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide

L Heifets  1 , T Sanchez
Affiliations

New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide

L Heifets et al. J Clin Microbiol. 2000 Apr.

Abstract

A new agar medium to perform pyrazinamide (PZA) susceptibility testing with Mycobacterium tuberculosis has been developed. This medium has an acidic pH of 6.0 instead of the usual for agar media, pH 6.8, to provide optimal conditions for PZA activity, and it also differs from conventional Middlebrook 7H10/7H11 agar in that animal serum (fetal or calf bovine or fetal equine serum) is used instead of oleic acid-albumin-dextrose-catalase to support good growth of M. tuberculosis at the low pH of 6.0. A critical concentration of 900 or 1,200 microg of PZA/ml in this medium made it possible to differentiate between PZA-susceptible and PZA-resistant clinical isolates. This agar medium has the following advantages compared to a liquid medium: it allows determination of the actual proportion of PZA-resistant bacteria in the isolate and it is simple and inexpensive. In addition, it has the potential of being used for a direct susceptibility test with PZA, but this approach will require further confirmation. Further studies to develop critical concentrations of other drugs for this low-pH medium, as well as to investigate the possibility of cultivation in regular (non-CO(2)) incubators, are in progress.

PubMed Disclaimer

References

    1. Butler W R, Kilburn J O. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol. 1982;16:1106–1109. - PMC - PubMed
    1. Butler W R, Kilburn J O. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother. 1983;24:600–601. - PMC - PubMed
    1. Heifets L, Cangelosi J. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis. 1999;3:564–581. - PubMed
    1. Heifets L B. Drug susceptibility tests in the management of chemotherapy of tuberculosis. In: Heifets L B, editor. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, Fla: CRC Press; 1991. pp. 89–122.
    1. Hewlett D, Horn D, Alfalla C. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA. 1995;273:916–917. . (Letter.) - PubMed

MeSH terms